NexgenRx, Inc. engages in the provision of administrative services only (ASO) (Self-Funded) drug, dental and extended health benefit plans supported by technology. The company is headquartered in Toronto, Ontario. The company went IPO on 2006-09-14. The firm administers, adjudicates and pays drug, dental and other extended healthcare claims for the beneficiaries of health benefit plans underwritten by its customers, using proprietary computer software and also providing ancillary services. The company offers plan sponsors, providers and patient support program/drug manufacturers a full suite of software-as-a-service solutions. The Company’s products include NexSys, NexAdmin, and NexPSPAssist. The NexSys is a fully integrated rules based adjudication platform for secure real-time processing of drug, dental and extended health benefit claims. Its NexAdmin product enables sponsors to take complete control of benefit plan administration. The NexPSPAssist service helps patient support programs (PSP) to optimize their deliverables to their manufacturer clients.
NEGXF stock price ended at $0.28 on 月曜日, after rising 40.00%
On the latest trading day Dec 15, 2025, the stock price of NEGXF rose by 40.00%, climbing from $0.28 to $0.28. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.28 and a high of $0.28. Alongside this price increase, trading volume also rose by 5.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 10.0K shares were traded, amounting to a market value of approximately $19.9M.